Kingdon Capital Management’s Aurinia Pharmaceuticals AUPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-1,583,208
| Closed | -$20.5M | – | 57 |
|
|
2021
Q2 | $20.5M | Sell |
1,583,208
-165,000
| -9% | -$2.14M | 2.38% | 9 |
|
|
2021
Q1 | $22.7M | Buy |
1,748,208
+80,000
| +5% | +$1.04M | 2.32% | 7 |
|
|
2020
Q4 | $23.1M | Buy |
1,668,208
+60,000
| +4% | +$830K | 2.5% | 8 |
|
|
2020
Q3 | $23.7M | Buy |
1,608,208
+257,400
| +19% | +$3.79M | 2.66% | 9 |
|
|
2020
Q2 | $22M | Buy |
1,350,808
+888,128
| +192% | +$14.4M | 2% | 9 |
|
|
2020
Q1 | $6.71M | Buy |
462,680
+419,011
| +960% | +$6.08M | 1.23% | 28 |
|
|
2019
Q4 | $885K | Buy |
+43,669
| New | +$885K | 0.13% | 42 |
|